Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa

Antiviral Research

Volumn 83, Issue 1, 2009, Pages 90-93

  Hurt, Aeron C ^a,b   Ernest, Joanne ^a   Deng, Yi Mo ^a   Iannello, Pina ^a   Besselaar, Terry G ^c   Birch, Chris ^d   Buchy, Philippe ^e   Chittaganpitch, Malinee ^f   Chiu, Shu Chun ^g   Dwyer, Dominic ^h   Guigon, Aurélie ⁱ   Harrower, Bruce ^j   Kei, Ip Peng ^k   Kok, Tuckweng ^l   Lin, Cui ^m   McPhie, Ken ^h   Mohd, Apandi ⁿ   Olveda, Remigio ^o   Panayotou, Tony ^p   Rawlinson, William ^q   Scott, Lesley ^r   Smith, David ^s   D'Souza, Holly ^t   Komadina, Naomi ^a   Shaw, Robert ^a   Kelso, Anne ^a   Barr, Ian G ^a,b   more..

^a WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

^b UNIVERSITY OF BALLARAT   (Australia)

^c NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^d VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^e INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g Centers for Disease Control   (Taiwan)

^h WESTMEAD HOSPITAL   (Australia)

ⁱ Pasteur Institute   (New Caledonia)

^j QUEENSLAND HEALTH   (Australia)

^k Health Bureau   (Macao)

^l INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^m MINISTRY OF HEALTH   (Singapore)

ⁿ Institute Penyelidikan Perubatan   (Malaysia)

^o RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^p Southern Health   (Australia)

^q PRINCE OF WALES HOSPITAL   (Australia)

^r Centre for Disease Control   (Australia)

^s PATHWEST LABORATORY MEDICINE   (Australia)

^t AUCKLAND CITY HOSPITAL   (New Zealand)

more..

Author keywords

Antivirals; H274Y; Influenza A; Neuraminidase inhibitors; Oseltamivir; Resistance; Tamiflu

Indexed keywords

OSELTAMIVIR; PERAMIVIR; SIALIDASE; ZANAMIVIR;

ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; ASIA; DISEASE SURVEILLANCE; GENE MUTATION; HUMAN; INFLUENZA VIRUS A H1N1; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PACIFIC ISLANDS; PRIORITY JOURNAL; SOUTH AFRICA; VIRUS VIRULENCE; WILD TYPE;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; ASIA, SOUTHEASTERN; CLUSTER ANALYSIS; CYCLOPENTANES; DRUG RESISTANCE, VIRAL; GUANIDINES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; NEURAMINIDASE; OCEANIA; OSELTAMIVIR; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SOUTH AFRICA; VIRAL PROTEINS; ZANAMIVIR;

ORTHOMYXOVIRIDAE;

EID: 67349139846     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.03.003     Document Type: Article

References (20)

1. Alexander, W.J., Harman, L.A., Collis, P.J., Elder, J., Kilpatrick, J.M., Atiee, G., Mead, E., 2007. Nasal and Pharyngeal Concentrations of Peramivir Following Intramuscular and Intravenous Administration in Health Volunteers, ICCAAC 2007 Conference Proceedings, Poster A-1410.
2. Barr I.G., Deng Y.M., Iannello P., Hurt A.C., and Komadina N. Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries. Antivir. Res. 80 (2008) 200-205
3. Besselaar T.G., Naidoo D., Buys A., Gregory V., McAnerney J., Manamela J.M., Blumberg L., and Schoub B.D. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg. Infect. Dis. 14 (2008) 1809-1810
4. Deyde V.M., Okomo-Adhiambo M., Sheu T.G., Wallis T.R., Fry A., Dharan N., Klimov A.I., and Gubareva L.V. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses. Antivir. Res. 81 (2009) 16-24
5. Felenstein J. PHYLIP-phylogeny inference package (version 3 2). Cladistics 5 (1989) 164-166
6. Gubareva L.V., Kaiser L., and Hayden F.G. Influenza virus neuraminidase inhibitors. Lancet 355 (2000) 827-835
7. Hauge S.H., Dudman S., Borgen K., Lackenby A., and Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg. Infect. Dis. 15 (2009) 155-162
8. Hurt A.C., and Barr I.G. Influenza viruses with reduced sensitivity to the NA inhibitor drugs in untreated young children. Commun. Dis. Intell. 32 (2008) 57-62
9. Hurt A.C., Barr I.G., Hartel G., and Hampson A.W. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antivir. Res. 62 (2004) 37-45
10. Ives J.A.L., Carr J.A., Mendel D.B., Tai C.Y., Lambkin R., Kelly L., Oxford J.S., Hayden F.G., and Roberts N.A. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antivir. Res. 55 (2002) 307-317
11. Kiso M., Mitamura K., Sakai-Tagawa Y., Shiraishi K., Kawakami C., Kimura K., Hayden F.G., Sugaya N., and Kawaoka Y. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364 (2004) 759-765
12. Lackenby A., Hungnes O., Dudman S., Meijer A., Pajet W., Hay A.J., and Zambon M.C. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro. Surveill. 13 (2008) 5
13. Monto A.S. Antivirals and influenza: frequency of resistance. Pediatr. Infect. Dis. J. 27 (2008) S110-S112
14. Monto A.S., McKimm-Breschkin J.L., Macken C., Hampson A.W., Hay A., Klimov A., Tashiro M., Webster R.G., Aymard M., Hayden F.G., and Zambon M. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob. Agents Chemother. 50 (2006) 2395-2402
15. Nicoll A., Ciancio B., and Kramarz P. Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications. Euro. Surveill. 13 (2008) 5
16. Roche Pharmaceuticals, 2006. Tamiflu (Oseltamivir carboxylate) Capsules and for Oral Suspension (www.tamiflu.com), Package Insert.
17. Russell C.A., Jones T.C., Barr I.G., Cox N.J., Garten R.J., Gregory V., Gust I.D., Hampson A.W., Hay A.J., Hurt A.C., De Jong J.C., Kelso A., Klimov A.I., Kageyama T., Komadina N., Lapedes A.S., Lin Y.P., Mosterin A., Obuchi M., Odagiri T., Osterhaus A.D., Rimmelzwaan G.F., Shaw M.W., Skepner E., Stohr K., Tashiro M., Fouchier R.A., and Smith D.J. The global circulation of seasonal influenza A (H3N2) viruses. Science 320 (2008) 340-346
18. Sheu T.G., Deyde V.M., Okomo-Adhiambo M., Garten R.J., Xu X., Bright R.A., Butler E.N., Wallis T.R., Klimov A.I., and Gubareva L.V. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 52 (2008) 3284-3292
19. Tamura, K., 1997. TreeExplorer.
20. WHO, 2008. http://www.who.int/csr/disease/influenza/h1n1_table/en/index.html (accessed 3 November 2008), website.